(EMAILWIRE.COM, August 23, 2018 ) Browse 190 market data Tables and 49 Figures spread through 273 Pages and in-depth TOC on "Pharmaceutical Excipients Market"
https://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html
Early buyers will receive 10% customization on this report.

Factors such as the growing pharmaceutical market with the rapidly aging population and increasing incidence of chronic disease, advancements in functional excipients, growing generics market propelled by the patent cliffs, and the rapidly growing biopharmaceuticals sector are driving the growth of the pharmaceutical excipients market.

Furthermore, the emergence of multifunctional & co-processed excipients, shifting focus of pharmaceutical manufacturing to emerging markets, and the growing biosimilars industry present significant opportunities for the growth of excipients. However, the increasing regulatory stringency, cost and time-intensive drug development process, and the quality concerns of excipient manufacturers represent a significant challenge to the market growth.

Refinements in the segments of the pharmaceutical excipients market

By Functionality: In the current edition of the report, the segment Emulsifying Agents has been added to the functionality chapter.
By Region: In the current edition of the report, the market for pharmaceutical excipients has been provided further for South Korea in the Asia Pacific region.

Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=956

The current edition of the report, consists of updated market overview and industry trends governing the market. The regulatory analysis section has also been updated for better market understanding.

Major developments that change the business landscape as well as market forecasts

The market witnessed the merger of two major players namely, The Dow Chemical Company and DuPont, making the combined entity–DowDuPont, the world’s largest chemical company. Furthermore, the acquisition FMC Corporation’s Health & Nutrition business enhanced DowDuPont’s position in the pharmaceutical excipients market, making it the leading players.

The current edition of the report, provides the updated competitive landscape of the market with market shares of the players at the global and regional (North America, Europe, and Asia Pacific) level.

Coverage of new market players in the pharmaceutical excipients market

Company profiles give a glimpse of the key players in the market with respect to business overview, financials, product offerings, and recent developments. In the new edition of the report, Kerry (Ireland), WACKER CHEMIE (Germany), Innophos Holdings (US), and Signet Chemicals (India) have been profiled as they have emerged as key market players in recent times due to various strategic investments, acquisitions and expansions they have done in the pharmaceutical excipients space. These strategic developments have challenged the status quo of industry leaders and it was prudent to analyze the changing business landscape.

Get the Sample Pages@
https://www.marketsandmarkets.com/requestsample.asp?id=956

Updated financial information/ product portfolio of players

The new edition of report provides updated financial information in context of the pharmaceutical excipients market till 2016/2017 for each listed company in graphical representation in single diagram (instead of multiple tables). This would help to easily analyze the present status of profiled companies in terms of their financial strength, profitability, key revenue generating region/country, business segment focus in terms of highest revenue generating segment and investment on research and development activities.

Updated market developments of profiled players

Recent developments are helpful to know the market trend and growth strategies adopted by players in the market. The current edition of the report provides updated developments of profiled players during 2014 – January 2018, indicating the continuation from previous edition. Expansion has been the principal growth strategy adopted by market players during the period of 2014- January 2018.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com